-
1
-
-
0025003393
-
Determinants of improved outcome in small cell lung cancer: An analysis of the 2,580-patients Southwest Oncology Group data base
-
Albain KS, Crowley JJ, LeBlanc M, Livingston RB (1990) Determinants of improved outcome in small cell lung cancer: an analysis of the 2,580-patients Southwest Oncology Group data base. J Clin Oncol 8: 1563-1574
-
(1990)
J Clin Oncol
, vol.8
, pp. 1563-1574
-
-
Albain, K.S.1
Crowley, J.J.2
LeBlanc, M.3
Livingston, R.B.4
-
2
-
-
0037245878
-
Lung Cancer Guidelines
-
American College of Chest Physicians (2003) Lung Cancer Guidelines. Chest 123 Supplement
-
(2003)
Chest
, vol.123
, Issue.SUPPL.
-
-
-
3
-
-
0346238665
-
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer
-
Arriagada R, Bergmann B, Dunant A et al. (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 350: 351-360
-
(2004)
N Engl J Med
, vol.350
, pp. 351-360
-
-
Arriagada, R.1
Bergmann, B.2
Dunant, A.3
-
4
-
-
0001138154
-
Bronchoskopische Behandlung tracheobronchialer Obturationen, Stenosen und muraler maligner Tumoren - Ein Leitfaden
-
Bölcskei P, Dierkesmann R, Becker HJ et al. (1998) Bronchoskopische Behandlung tracheobronchialer Obturationen, Stenosen und muraler maligner Tumoren - ein Leitfaden. Pneumologie 52: 243-248
-
(1998)
Pneumologie
, vol.52
, pp. 243-248
-
-
Bölcskei, P.1
Dierkesmann, R.2
Becker, H.J.3
-
5
-
-
0031892132
-
Functional evaluation of the lung resection candidate
-
Bolliger C, Perruchoud A (1998) Functional evaluation of the lung resection candidate. Eur Respir J 11: 198-212
-
(1998)
Eur Respir J
, vol.11
, pp. 198-212
-
-
Bolliger, C.1
Perruchoud, A.2
-
6
-
-
22444432345
-
ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (Stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up
-
#7013
-
Douillard JY, Rosell R, Delena M et al. (2005) ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (Stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. J Clin Oncol 24 (Suppl) #7013
-
(2005)
J Clin Oncol
, vol.24
, Issue.SUPPL.
-
-
Douillard, J.Y.1
Rosell, R.2
Delena, M.3
-
7
-
-
0035397994
-
Randomized phase III trial of paclitaxel plus caboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial
-
Kelly K, Crowley J, Bunn PA (2001) Randomized phase III trial of paclitaxel plus caboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol 19: 3210-3218
-
(2001)
J Clin Oncol
, vol.19
, pp. 3210-3218
-
-
Kelly, K.1
Crowley, J.2
Bunn, P.A.3
-
8
-
-
0030912190
-
Revisions in the international system for staging lung cancer
-
Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111: 1710-1717
-
(1997)
Chest
, vol.111
, pp. 1710-1717
-
-
Mountain, C.F.1
-
9
-
-
0028843552
-
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
-
Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311: 899-909
-
(1995)
BMJ
, vol.311
, pp. 899-909
-
-
-
10
-
-
16244371591
-
-
Travis WD, Brambilla E, Müller-Hermelink, HK and Harris CC (eds) IARC Press, Lyon
-
Travis WD, Brambilla E, Müller-Hermelink, HK and Harris CC (eds) (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon
-
(2004)
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart
-
-
-
12
-
-
0037050352
-
Comparison of four chemotherapy regimes for advanced non-small-cell lung cancer
-
Schiller JH, Harrington D, Belani CP et al. (2002) Comparison of four chemotherapy regimes for advanced non-small-cell lung cancer. N Engl J Med 346: 92-98
-
(2002)
N Engl J Med
, vol.346
, pp. 92-98
-
-
Schiller, J.H.1
Harrington, D.2
Belani, C.P.3
-
13
-
-
10244233949
-
Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633
-
Strauss GM, Herndon J, Maddaus MA et al. (2004) Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. J Clin Oncol 22: 621
-
(2004)
J Clin Oncol
, vol.22
, pp. 621
-
-
Strauss, G.M.1
Herndon, J.2
Maddaus, M.A.3
-
14
-
-
20544455590
-
A prospective randomised trial of adjuvant vinorelbine and cisplatin in completely resected stage IB and II non-small-cell lung cancer
-
Intergroup JBR.10
-
Winton TL, Livingston R, Johnson D et al. (2005) A prospective randomised trial of adjuvant vinorelbine and cisplatin in completely resected stage IB and II non-small-cell lung cancer. Intergroup JBR.10. N Engl J Med 352: 2589-2597
-
(2005)
N Engl J Med
, vol.352
, pp. 2589-2597
-
-
Winton, T.L.1
Livingston, R.2
Johnson, D.3
-
15
-
-
0003492825
-
-
Wittekind C, Meyer HJ, Bootz F (Hrsg) Springer, Berlin Heidelberg New York
-
Wittekind C, Meyer HJ, Bootz F (Hrsg) (2002) TNM-Klassifikation maligner Tumoren. Springer, Berlin Heidelberg New York
-
(2002)
TNM-Klassifikation Maligner Tumoren
-
-
|